Selected research
Market Outlook & Growth Opportunities
Global Active Peptide Cosmetics Market Outlook and Growth Opportunities 2026
Market perspective
The global Active Peptide Cosmetics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Active Peptide Cosmetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Active Peptide Cosmetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Active Peptide Cosmetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Active Peptide Cosmetics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Active Peptide Cosmetics market include L’Oréal, Estée Lauder, Unilever, Procter & Gamble, Avon Products (Natura &Co), Shiseido, Colgate-Palmolive, Geoskincare (nzskincare) and DECIEM, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Active Peptide Cosmetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Active Peptide Cosmetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Active Peptide Cosmetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Active Peptide Cosmetics market size, projected growth trends, production technologies, key applications, and end-use industries.
Active Peptide Cosmetics Segment by Company
L’Oréal
Estée Lauder
Unilever
Procter & Gamble
Avon Products (Natura &Co)
Shiseido
Colgate-Palmolive
Geoskincare (nzskincare)
DECIEM
Revision Skincare
Peter Thomas Roth
Jan Marini Skin Research
Eminence Organic Skin Care
BrandMD Skincare
Vivier Pharma
Prima-Derm
Sisley
StriVectin (Crown Laboratories)
Elizabeth Arden (Revlon)
SkinMedica (Allergan)
NeoStrata (Johnson & Johnson)
Alastin Skincare
IMAGE Skincare
Mario Badescu
Elemis (L'Occitane)
Proya
Active Peptide Cosmetics Segment by Type
Serums
Moisturizers
Face Cream
Eyes Cream
Others
Active Peptide Cosmetics Segment by Application
Supermarket
Specialty Retailers
Online Sales
Others
Active Peptide Cosmetics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Active Peptide Cosmetics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Active Peptide Cosmetics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Active Peptide Cosmetics significant trends, drivers, influence factors in global and regions.
6. To analyze Active Peptide Cosmetics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Active Peptide Cosmetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Active Peptide Cosmetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Active Peptide Cosmetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Active Peptide Cosmetics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Active Peptide Cosmetics industry.
Chapter 3: Detailed analysis of Active Peptide Cosmetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Active Peptide Cosmetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Active Peptide Cosmetics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Serums
- Moisturizers
- Face Cream
- Eyes Cream
- Others
Applications
- Supermarket
- Specialty Retailers
- Online Sales
- Others
Companies covered
- L’Oréal
- Estée Lauder
- Unilever
- Procter & Gamble
- Avon Products (Natura &Co)
- Shiseido
- Colgate-Palmolive
- Geoskincare (nzskincare)
- DECIEM
- Revision Skincare
- Peter Thomas Roth
- Jan Marini Skin Research
- Eminence Organic Skin Care
- BrandMD Skincare
- Vivier Pharma
- Prima-Derm
- Sisley
- StriVectin (Crown Laboratories)
- Elizabeth Arden (Revlon)
- SkinMedica (Allergan)
- NeoStrata (Johnson & Johnson)
- Alastin Skincare
- IMAGE Skincare
- Mario Badescu
- Elemis (L'Occitane)
- Proya
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Active Peptide Cosmetics Sales Value (2021-2032)
- 1.2.2 Global Active Peptide Cosmetics Sales Volume (2021-2032)
- 1.2.3 Global Active Peptide Cosmetics Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Active Peptide Cosmetics Market Dynamics
- 2.1 Active Peptide Cosmetics Industry Trends
- 2.2 Active Peptide Cosmetics Industry Drivers
- 2.3 Active Peptide Cosmetics Industry Opportunities and Challenges
- 2.4 Active Peptide Cosmetics Industry Restraints
3 Active Peptide Cosmetics Market by Company
- 3.1 Global Active Peptide Cosmetics Company Revenue Ranking in 2025
- 3.2 Global Active Peptide Cosmetics Revenue by Company (2021-2026)
- 3.3 Global Active Peptide Cosmetics Sales Volume by Company (2021-2026)
- 3.4 Global Active Peptide Cosmetics Average Price by Company (2021-2026)
- 3.5 Global Active Peptide Cosmetics Company Ranking (2024-2026)
- 3.6 Global Active Peptide Cosmetics Company Manufacturing Base and Headquarters
- 3.7 Global Active Peptide Cosmetics Company Product Type and Application
- 3.8 Global Active Peptide Cosmetics Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Active Peptide Cosmetics Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Active Peptide Cosmetics Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Active Peptide Cosmetics Market by Type
- 4.1 Active Peptide Cosmetics Type Introduction
- 4.1.1 Serums
- 4.1.2 Moisturizers
- 4.1.3 Face Cream
- 4.1.4 Eyes Cream
- 4.1.5 Others
- 4.2 Global Active Peptide Cosmetics Sales Volume by Type
- 4.2.1 Global Active Peptide Cosmetics Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Active Peptide Cosmetics Sales Volume by Type (2021-2032)
- 4.2.3 Global Active Peptide Cosmetics Sales Volume Share by Type (2021-2032)
- 4.3 Global Active Peptide Cosmetics Sales Value by Type
- 4.3.1 Global Active Peptide Cosmetics Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Active Peptide Cosmetics Sales Value by Type (2021-2032)
- 4.3.3 Global Active Peptide Cosmetics Sales Value Share by Type (2021-2032)
5 Active Peptide Cosmetics Market by Application
- 5.1 Active Peptide Cosmetics Application Introduction
- 5.1.1 Supermarket
- 5.1.2 Specialty Retailers
- 5.1.3 Online Sales
- 5.1.4 Others
- 5.2 Global Active Peptide Cosmetics Sales Volume by Application
- 5.2.1 Global Active Peptide Cosmetics Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Active Peptide Cosmetics Sales Volume by Application (2021-2032)
- 5.2.3 Global Active Peptide Cosmetics Sales Volume Share by Application (2021-2032)
- 5.3 Global Active Peptide Cosmetics Sales Value by Application
- 5.3.1 Global Active Peptide Cosmetics Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Active Peptide Cosmetics Sales Value by Application (2021-2032)
- 5.3.3 Global Active Peptide Cosmetics Sales Value Share by Application (2021-2032)
6 Active Peptide Cosmetics Regional Sales and Value Analysis
- 6.1 Global Active Peptide Cosmetics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Active Peptide Cosmetics Sales by Region (2021-2032)
- 6.2.1 Global Active Peptide Cosmetics Sales by Region: 2021-2026
- 6.2.2 Global Active Peptide Cosmetics Sales by Region (2027-2032)
- 6.3 Global Active Peptide Cosmetics Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Active Peptide Cosmetics Sales Value by Region (2021-2032)
- 6.4.1 Global Active Peptide Cosmetics Sales Value by Region: 2021-2026
- 6.4.2 Global Active Peptide Cosmetics Sales Value by Region (2027-2032)
- 6.5 Global Active Peptide Cosmetics Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Active Peptide Cosmetics Sales Value (2021-2032)
- 6.6.2 North America Active Peptide Cosmetics Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Active Peptide Cosmetics Sales Value (2021-2032)
- 6.7.2 Europe Active Peptide Cosmetics Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Active Peptide Cosmetics Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Active Peptide Cosmetics Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Active Peptide Cosmetics Sales Value (2021-2032)
- 6.9.2 South America Active Peptide Cosmetics Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Active Peptide Cosmetics Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Active Peptide Cosmetics Sales Value Share by Country, 2025 VS 2032
7 Active Peptide Cosmetics Country-level Sales and Value Analysis
- 7.1 Global Active Peptide Cosmetics Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Active Peptide Cosmetics Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Active Peptide Cosmetics Sales by Country (2021-2032)
- 7.3.1 Global Active Peptide Cosmetics Sales by Country (2021-2026)
- 7.3.2 Global Active Peptide Cosmetics Sales by Country (2027-2032)
- 7.4 Global Active Peptide Cosmetics Sales Value by Country (2021-2032)
- 7.4.1 Global Active Peptide Cosmetics Sales Value by Country (2021-2026)
- 7.4.2 Global Active Peptide Cosmetics Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.9.2 France Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.16.2 China Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.19.2 India Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Active Peptide Cosmetics Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Active Peptide Cosmetics Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Active Peptide Cosmetics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 L’Oréal
- 8.1.1 L’Oréal Company Information
- 8.1.2 L’Oréal Business Overview
- 8.1.3 L’Oréal Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.1.4 L’Oréal Active Peptide Cosmetics Product Portfolio
- 8.1.5 L’Oréal Recent Developments
- 8.2 Estée Lauder
- 8.2.1 Estée Lauder Company Information
- 8.2.2 Estée Lauder Business Overview
- 8.2.3 Estée Lauder Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Estée Lauder Active Peptide Cosmetics Product Portfolio
- 8.2.5 Estée Lauder Recent Developments
- 8.3 Unilever
- 8.3.1 Unilever Company Information
- 8.3.2 Unilever Business Overview
- 8.3.3 Unilever Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Unilever Active Peptide Cosmetics Product Portfolio
- 8.3.5 Unilever Recent Developments
- 8.4 Procter & Gamble
- 8.4.1 Procter & Gamble Company Information
- 8.4.2 Procter & Gamble Business Overview
- 8.4.3 Procter & Gamble Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Procter & Gamble Active Peptide Cosmetics Product Portfolio
- 8.4.5 Procter & Gamble Recent Developments
- 8.5 Avon Products (Natura &Co)
- 8.5.1 Avon Products (Natura &Co) Company Information
- 8.5.2 Avon Products (Natura &Co) Business Overview
- 8.5.3 Avon Products (Natura &Co) Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Avon Products (Natura &Co) Active Peptide Cosmetics Product Portfolio
- 8.5.5 Avon Products (Natura &Co) Recent Developments
- 8.6 Shiseido
- 8.6.1 Shiseido Company Information
- 8.6.2 Shiseido Business Overview
- 8.6.3 Shiseido Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Shiseido Active Peptide Cosmetics Product Portfolio
- 8.6.5 Shiseido Recent Developments
- 8.7 Colgate-Palmolive
- 8.7.1 Colgate-Palmolive Company Information
- 8.7.2 Colgate-Palmolive Business Overview
- 8.7.3 Colgate-Palmolive Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Colgate-Palmolive Active Peptide Cosmetics Product Portfolio
- 8.7.5 Colgate-Palmolive Recent Developments
- 8.8 Geoskincare (nzskincare)
- 8.8.1 Geoskincare (nzskincare) Company Information
- 8.8.2 Geoskincare (nzskincare) Business Overview
- 8.8.3 Geoskincare (nzskincare) Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Geoskincare (nzskincare) Active Peptide Cosmetics Product Portfolio
- 8.8.5 Geoskincare (nzskincare) Recent Developments
- 8.9 DECIEM
- 8.9.1 DECIEM Company Information
- 8.9.2 DECIEM Business Overview
- 8.9.3 DECIEM Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.9.4 DECIEM Active Peptide Cosmetics Product Portfolio
- 8.9.5 DECIEM Recent Developments
- 8.10 Revision Skincare
- 8.10.1 Revision Skincare Company Information
- 8.10.2 Revision Skincare Business Overview
- 8.10.3 Revision Skincare Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Revision Skincare Active Peptide Cosmetics Product Portfolio
- 8.10.5 Revision Skincare Recent Developments
- 8.11 Peter Thomas Roth
- 8.11.1 Peter Thomas Roth Company Information
- 8.11.2 Peter Thomas Roth Business Overview
- 8.11.3 Peter Thomas Roth Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Peter Thomas Roth Active Peptide Cosmetics Product Portfolio
- 8.11.5 Peter Thomas Roth Recent Developments
- 8.12 Jan Marini Skin Research
- 8.12.1 Jan Marini Skin Research Company Information
- 8.12.2 Jan Marini Skin Research Business Overview
- 8.12.3 Jan Marini Skin Research Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Jan Marini Skin Research Active Peptide Cosmetics Product Portfolio
- 8.12.5 Jan Marini Skin Research Recent Developments
- 8.13 Eminence Organic Skin Care
- 8.13.1 Eminence Organic Skin Care Company Information
- 8.13.2 Eminence Organic Skin Care Business Overview
- 8.13.3 Eminence Organic Skin Care Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Eminence Organic Skin Care Active Peptide Cosmetics Product Portfolio
- 8.13.5 Eminence Organic Skin Care Recent Developments
- 8.14 BrandMD Skincare
- 8.14.1 BrandMD Skincare Company Information
- 8.14.2 BrandMD Skincare Business Overview
- 8.14.3 BrandMD Skincare Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.14.4 BrandMD Skincare Active Peptide Cosmetics Product Portfolio
- 8.14.5 BrandMD Skincare Recent Developments
- 8.15 Vivier Pharma
- 8.15.1 Vivier Pharma Company Information
- 8.15.2 Vivier Pharma Business Overview
- 8.15.3 Vivier Pharma Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Vivier Pharma Active Peptide Cosmetics Product Portfolio
- 8.15.5 Vivier Pharma Recent Developments
- 8.16 Prima-Derm
- 8.16.1 Prima-Derm Company Information
- 8.16.2 Prima-Derm Business Overview
- 8.16.3 Prima-Derm Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Prima-Derm Active Peptide Cosmetics Product Portfolio
- 8.16.5 Prima-Derm Recent Developments
- 8.17 Sisley
- 8.17.1 Sisley Company Information
- 8.17.2 Sisley Business Overview
- 8.17.3 Sisley Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Sisley Active Peptide Cosmetics Product Portfolio
- 8.17.5 Sisley Recent Developments
- 8.18 StriVectin (Crown Laboratories)
- 8.18.1 StriVectin (Crown Laboratories) Company Information
- 8.18.2 StriVectin (Crown Laboratories) Business Overview
- 8.18.3 StriVectin (Crown Laboratories) Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.18.4 StriVectin (Crown Laboratories) Active Peptide Cosmetics Product Portfolio
- 8.18.5 StriVectin (Crown Laboratories) Recent Developments
- 8.19 Elizabeth Arden (Revlon)
- 8.19.1 Elizabeth Arden (Revlon) Company Information
- 8.19.2 Elizabeth Arden (Revlon) Business Overview
- 8.19.3 Elizabeth Arden (Revlon) Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Elizabeth Arden (Revlon) Active Peptide Cosmetics Product Portfolio
- 8.19.5 Elizabeth Arden (Revlon) Recent Developments
- 8.20 SkinMedica (Allergan)
- 8.20.1 SkinMedica (Allergan) Company Information
- 8.20.2 SkinMedica (Allergan) Business Overview
- 8.20.3 SkinMedica (Allergan) Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.20.4 SkinMedica (Allergan) Active Peptide Cosmetics Product Portfolio
- 8.20.5 SkinMedica (Allergan) Recent Developments
- 8.21 NeoStrata (Johnson & Johnson)
- 8.21.1 NeoStrata (Johnson & Johnson) Company Information
- 8.21.2 NeoStrata (Johnson & Johnson) Business Overview
- 8.21.3 NeoStrata (Johnson & Johnson) Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.21.4 NeoStrata (Johnson & Johnson) Active Peptide Cosmetics Product Portfolio
- 8.21.5 NeoStrata (Johnson & Johnson) Recent Developments
- 8.22 Alastin Skincare
- 8.22.1 Alastin Skincare Company Information
- 8.22.2 Alastin Skincare Business Overview
- 8.22.3 Alastin Skincare Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Alastin Skincare Active Peptide Cosmetics Product Portfolio
- 8.22.5 Alastin Skincare Recent Developments
- 8.23 IMAGE Skincare
- 8.23.1 IMAGE Skincare Company Information
- 8.23.2 IMAGE Skincare Business Overview
- 8.23.3 IMAGE Skincare Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.23.4 IMAGE Skincare Active Peptide Cosmetics Product Portfolio
- 8.23.5 IMAGE Skincare Recent Developments
- 8.24 Mario Badescu
- 8.24.1 Mario Badescu Company Information
- 8.24.2 Mario Badescu Business Overview
- 8.24.3 Mario Badescu Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Mario Badescu Active Peptide Cosmetics Product Portfolio
- 8.24.5 Mario Badescu Recent Developments
- 8.25 Elemis (L'Occitane)
- 8.25.1 Elemis (L'Occitane) Company Information
- 8.25.2 Elemis (L'Occitane) Business Overview
- 8.25.3 Elemis (L'Occitane) Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.25.4 Elemis (L'Occitane) Active Peptide Cosmetics Product Portfolio
- 8.25.5 Elemis (L'Occitane) Recent Developments
- 8.26 Proya
- 8.26.1 Proya Company Information
- 8.26.2 Proya Business Overview
- 8.26.3 Proya Active Peptide Cosmetics Sales, Value and Gross Margin (2021-2026)
- 8.26.4 Proya Active Peptide Cosmetics Product Portfolio
- 8.26.5 Proya Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Active Peptide Cosmetics Value Chain Analysis
- 9.1.1 Active Peptide Cosmetics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Active Peptide Cosmetics Sales Mode & Process
- 9.2 Active Peptide Cosmetics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Active Peptide Cosmetics Distributors
- 9.2.3 Active Peptide Cosmetics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst